SAMPHIRE NEUROSCIENCE LTD
Executive Summary
Samphire Neuroscience Ltd exhibits strong liquidity and growing net assets, reflecting good financial health despite accumulated losses typical of an early-stage company. The company’s healthy cash reserves and working capital provide a sound foundation for continued growth, though focus on improving profitability is essential. Maintaining strong cash flow management and careful inventory control will support a positive financial trajectory going forward.
View Full Analysis Report →Company Documents
Date | Description |
---|---|
21/01/2521 January 2025 | Notification of a person with significant control statement |
21/01/2521 January 2025 | Cessation of Emilė Radytė as a person with significant control on 2024-12-23 |
21/01/2521 January 2025 | Cessation of Alexander Anthony Cook as a person with significant control on 2024-12-23 |
15/01/2515 January 2025 | Unaudited abridged accounts made up to 2024-09-30 |
08/01/258 January 2025 | Memorandum and Articles of Association |
08/01/258 January 2025 | Resolutions |
06/01/256 January 2025 | Statement of capital following an allotment of shares on 2024-12-13 |
30/09/2430 September 2024 | Annual accounts for year ending 30 Sep 2024 |
04/09/244 September 2024 | Confirmation statement made on 2024-09-01 with updates |
27/01/2427 January 2024 | Resolutions |
27/01/2427 January 2024 | Memorandum and Articles of Association |
27/01/2427 January 2024 | Resolutions |
27/01/2427 January 2024 | Resolutions |
27/01/2427 January 2024 | Resolutions |
27/01/2427 January 2024 | Resolutions |
24/01/2424 January 2024 | Statement of capital following an allotment of shares on 2023-12-21 |
21/01/2421 January 2024 | Memorandum and Articles of Association |
09/01/249 January 2024 | Unaudited abridged accounts made up to 2023-09-30 |
24/10/2324 October 2023 | Change of details for Mr Alexander Anthony Cook as a person with significant control on 2023-10-24 |
30/09/2330 September 2023 | Annual accounts for year ending 30 Sep 2023 |
03/09/233 September 2023 | Confirmation statement made on 2023-09-01 with no updates |
29/03/2329 March 2023 | Director's details changed for Ms Emilė Radytė on 2022-07-12 |
29/03/2329 March 2023 | Change of details for Ms Emilė Radytė as a person with significant control on 2022-07-12 |
28/03/2328 March 2023 | Change of details for Mr Alexander Anthony Cook as a person with significant control on 2021-11-25 |
28/03/2328 March 2023 | Director's details changed for Mr Alexander Anthony Cook on 2021-11-25 |
15/02/2315 February 2023 | Unaudited abridged accounts made up to 2022-09-30 |
30/09/2230 September 2022 | Annual accounts for year ending 30 Sep 2022 |
01/02/221 February 2022 | Certificate of change of name |
30/11/2130 November 2021 | Change of details for Mr Alexander Anthony Cook as a person with significant control on 2021-11-24 |
30/11/2130 November 2021 | Change of details for Ms Emilė Radytė as a person with significant control on 2021-11-24 |
30/11/2130 November 2021 | Registered office address changed from 3/12 Abbey Road Oxford OX2 0AE England to 85 Great Portland Street First Floor London W1W 7LT on 2021-11-30 |
30/11/2130 November 2021 | Director's details changed for Ms Emilė Radytė on 2021-11-24 |
30/11/2130 November 2021 | Director's details changed for Mr Alexander Anthony Cook on 2021-11-25 |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company